Citicoline

This classification denotes a nootropic agent with the molecular formula C14H25N4O11P2.H+, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 536BQ2JVC7, chemically known as cytidine 5-(trihydrogen pyrophosphate), monoester with choline hydroxide, inner salt but generally known as citicoline, which bears US NIH Compound Identifier 291. European Medicines Agency schedules Citicoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07489MIG. World Health Organization schedules citicoline in its Anatomical Therapeutic Chemical (ATC) Classification. CITICOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule citicoline under HS 29349990 and SITC 51579. As of Q4 2014, CITICOLINE remains the US FDA Preferred Term for this commodity. Citicoline bears US NLM identifiers UMLS ID C0010725 and NCI Concept Code C96743. SMILES: P(=O)(OCC1OC(N2CCC(NC2=O)N)C(O)C1O)(OP(=O)(OCC[N](C)(C)C)O)O.